Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

NCT02879578 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurocrine Biosciences